Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort vs Budesonide in Well-Controlled Asthma Step-Down
NCT02725242Phase 3Completed
- Sponsor
- Hat Yai Hospital Medical Education Center
- Start
- Mar 2016
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of budesonide in asthma, sponsored by Hat Yai Hospital Medical Education Center. Primary endpoint: Asthma Control Questionnaire at 12 weeks. Started Mar 2016; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02725242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02725242.